Quarterly Results

  • Company Name :
Cipla Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 500087
  • NSE Symbol:
  • CIPLA
  • P/E(TTM):
  • 23.79
  • ISIN Demat:
  • INE059A01026
  • Div & Yield%:
  • 1.04
  • EPS(TTM):
  • 64.35
  • Book Value(₹):
  • 411.56
  • Market Cap(₹Cr.):
  • 123,665.73
  • Face Value(₹):
  • 2.00
Quarters :  
Particulars September 2025 ( Cr)June 2025 ( Cr)March 2025 ( Cr)
Gross Sales 4,495.16 4,501.66 4,254.47
Excise Duty 0.00 0.00 0.00
Net Sales 4,495.16 4,501.66 4,254.47
Other Operating Income 730.56 544.51 543.42
Other Income 254.66 271.07 588.03
Total Income 5,480.38 5,317.24 5,385.92
Total Expenditure 3,703.09 3,421.72 3,479.18
PBIDT 1,777.29 1,895.52 1,906.74
Interest 2.65 5.88 3.49
PBDT 1,774.64 1,889.64 1,903.25
Depreciation 141.30 145.69 147.70
Tax 412.22 456.04 332.71
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 10.59 -15.22 -62.56
Reported Profit After Tax 1,210.53 1,303.13 1,485.40
Extra-ordinary Items 0.00 0.00 238.82
Adjusted Profit After Extra-ordinary item 1,210.53 1,303.13 1,246.58
EPS (Unit Curr.) 14.99 16.13 18.39
EPS (Adj) (Unit Curr.) 14.99 16.13 18.39
Calculated EPS (Unit Curr.) 14.99 16.13 18.39
Calculated EPS (Adj) (Unit Curr.) 14.99 16.13 18.39
Calculated EPS (Ann.) (Unit Curr.) 59.95 64.53 73.57
Calculated EPS (Adj) (Ann.) (Unit Curr.) 59.95 64.53 73.57
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 161.55 161.55 161.52
Reserve & Surplus 0.00 0.00 0.00
Face Value 2.00 2.00 2.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 39.54 42.11 44.82
PBDTM(%) 39.48 41.98 44.74
PATM(%) 26.93 28.95 34.91